Cystic fibrosis (CF) is the most common autosomal recessive disorder in Caucasian people
and is caused by mutations in the gene encoding for the CF transmembrane conductance …

The use of extracorporeal life support (ECLS) for the pediatric and neonatal population
continues to grow. At the same time, there have been dramatic improvements in the …

Pediatric lung transplant is a viable option for treatment of end-stage lung disease in
children, with> 100 pediatric lung transplants reported to the Registry of the International …

Background Survival outcomes of children on extracorporeal membrane oxygenation
(ECMO) at time of lung transplant (LTx) remain unclear. Methods Pediatric first‐time LTx …

Extracorporeal membrane oxygenation (ECMO) is an invaluable resource in the treatment of
critically ill children with cardiopulmonary failure. To date over 36,000 children have been …

Background “Bridging” is a term used to describe the implementation of various treatment
modalities to improve waitlist survival while a patient awaits lung transplantation. ECMO and …

Pediatric lung transplantation: supply and demand : Current Opinion in Organ
Transplantation Pediatric lung transplantation: supply and demand : Current Opinion in …

BACKGROUND Access to timely suitably size-matched quality organs remains a challenge
for pediatric (pLTx) and adult (aLTx) lung transplantation. The outcomes of donation after …

Lung transplantation (LT) has been an effective treatment for carefully selected children with
end-stage lung diseases. The aim of this retrospective study is to introduce our experience …

In children with pulmonary arterial hypertension, lung transplantation illustrates a feasible
treatment option once pharmacological therapy is exhausted. Timing of listing for lung …